Pfizer/BioNTech

8% Of Americans Fail To Take The 2nd Vaccination Dose

  • The CDC reported Sunday that 95 million people have been fully vaccinated.
  • About 229 million doses of Covid-19 vaccines have been administered in the United States.
  • Experts have estimated somewhere between 70% to 85% of Americans need to have immunity to the virus to control its spread.
  • A growing number of Americans have missed their scheduled second dose of a Covid-19 vaccine.
  • The vaccines by Pfizer/BioNTech and Moderna require two doses to be considered fully effective.

It’s not an exact...

https://mfame.guru/8-of-americans-fail-to-take-the-2nd-vaccination-dose/

5,800 Vaccinated Americans Contract COVID-19

About 5,800 people who have been vaccinated against coronavirus have become infected anyway, the US Centers for Disease Control and Prevention tells CNN. Some became seriously ill and 74 people died, the CDC said. It said 396 — 7% — of those who got infected after they were vaccinated required hospitalization, reports CNN.

Breakthrough cases

This is the CDC’s first public accounting of breakthrough cases, and the agency is searching for patterns based on patient age and gender, location, type...

https://mfame.guru/5800-vaccinated-americans-contract-covid-19/

Global COVID Infections Near 140 Million

The global Covid death toll has passed 2.97 million. Meanwhile, infections have passed 138 million world wide, according to analysts at Johns Hopkins University, reports, Pharmaceutical Technology.

Origin of the virus

US Covid -19 infections exceed 31.4 million. Meanwhile, the US coronavirus death toll is more than 564,000 according to analysts at Johns Hopkins University.

US spy agencies have yet to determine the source of the virus that causes Covid-19, top intelligence officials told the Senate...

https://mfame.guru/international-coronavirus-update-vaccine-cases-lockdowns/

Inactivated SARS-CoV-2 Vaccines May Prove To Be Unreliable Against Variants

Despite the theoretical potential of inactivated virus vaccines to offer a lead over other Covid-19 vaccine technologies against variants of concern, experts said they are unlikely to be a long-term solution, reports Clinical Trials Arena.

Infections variants 

Despite the theoretical potential of inactivated virus vaccines to offer a lead over other Covid-19 vaccine technologies against variants of concern, experts said they are unlikely to be a long-term solution. While it is logical...

https://mfame.guru/inactivated-sars-cov-2-vaccines-may-prove-to-be-unreliable-against-variants/

New Data Shows Severe COVID-19 In Older Adults Reduce By Vaccinations

New data show both Pfizer-BioNTech and Oxford-AstraZeneca vaccines significantly reduce severe COVID-19 in older adults, says an article published in Gov.uk.

PHE’s Real-world Study

On March 1, 2021, Public Health England (PHE) has submitted a pre-print of a real-world study that shows that both the Pfizer and Oxford-AstraZeneca vaccines are highly effective in reducing COVID-19 infections among older people aged 70 years and over. Since January, protection against symptomatic COVID, 4 weeks after...

https://mfame.guru/new-data-shows-severe-covid-19-in-older-adults-reduce-by-vaccinations/

Experts Warn Against Easing Up On Safety Protocols After Third Vaccine’s Approval

There’s good Covid-19 news, including a third vaccine’s approval. But don’t ease up on safety measures, Fauci warns, reports CNN.

A false sense of security 

It’s easy to get caught up in all the good news about the Covid-19 pandemic. Vaccine advisers to the US Centers for Disease Control and Prevention unanimously voted Sunday to recommend the distribution of a third vaccine for Americans 18 and older: the one-dose Johnson & Johnson vaccine.

And for the first time since early November, fewer than...

https://mfame.guru/experts-warn-against-easing-up-on-safety-protocols-after-third-vaccines-approval/

Pfizer 2021 Vaccine Sales Projection $15 Billion

According to a Bloomberg report, Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot.

Vaccine Can Tackle New Variants

Company officials led by Chief Executive Albert Bourla said on a conference call that the vaccine looks capable of taking on new variants, its price may increase and new products using its messenger RNA technology are on the way....

https://mfame.guru/pfizer-2021-vaccine-sales-projection-15-billion/

Dose Confusion in Pfizer COVID Vaccine Vials

As the coronavirus vaccination has begun there’s a confusion regarding Pfizer’s vaccine doses, reports the Economic Times. 

The vaccine is supplied in vials and people are not sure whether it’s 5 or 6 doses of the vials that will complete the vaccination.

Meanwhile Pfizer has said its contracts specify the delivery of a certain number of vaccine doses and not vials.

What’s the confusion?

Pfizer has revised higher its production target for this year from 1.3 billion doses to 2 billion. While part...

https://mfame.guru/dose-confusion-in-pfizer-covid-vaccine-vials/

Tug of War for Fair Distribution of Covid 19 Vaccine in Europe

  • The EU has warned Covid vaccine producers they must deliver agreed supplies, amid fears reductions could seriously hamper its inoculation drive.
  • AstraZeneca and Pfizer-BioNTech have both said production problems mean they cannot supply the expected numbers.
  • The EU warned it could restrict exports of vaccines made in the bloc, with Germany’s health minister demanding “fair distribution”.
  • The UK’s vaccine minister warned of “the dead end of vaccine nationalism”.

A recent news article published...

https://mfame.guru/tug-of-war-for-fair-distribution-of-covid-19-vaccine-in-europe/

US Revamps Vaccination Criteria Amid Surging Deaths

  • U.S. federal officials agreed to send states additional coronavirus vaccine doses requested by several governors, as the country tries to ramp up the pace of inoculations.
  • Officials also recommended that states broaden vaccination eligibility to people as young as 65 or who have other chronic health conditions.

The Trump administration moved on to accelerate vaccinations of Americans against COVID-19, releasing the rest of the doses it had been keeping in reserve and recommending states...

https://mfame.guru/us-revamps-vaccination-criteria-amid-surging-deaths/

+ More